share_log

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26

Canaccord Genuity维持对Privia Health Gr的买入,将目标股价下调至26美元
Benzinga ·  05/10 14:46

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $37 to $26.

Canaccord Genuity分析师理查德·克洛斯维持Privia Health Gr(纳斯达克股票代码:PRVA)的买入并将目标股价从37美元下调至26美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发